化纤方治疗肝纤维化87例疗效观察  

Efficacy Observation on Huaqian Decoction for the Treatment of 87 cases of Hepatic Fibrosis

作　　者：彭立生[1] 周大桥[1] 李卫青[2] 魏平[2] 

机构地区：[1]深圳市中医院,广东深圳518033 [2]深圳市罗湖区人民医院,广东深圳518001

出　　处：《湖南中医药导报》2003年第9期10-13,共4页Hunan Guiding Journal of Traditional Chinese Medicine and Pharmacology

基　　金：广东省中医局科研课题 (课题编号 :984 46 )

摘　　要：目的 :观察中药化纤方抗慢性肝病肝纤维化的作用 ,研制抗肝纤维化的有效新药。方法 :采用化纤方治疗慢性肝病患者 87例 ,疗程 0 .5年 ;与秋水仙碱治疗 87例作对照。结果 :治疗组与对照组临床疗效相当 (P >0 .0 5 ) ;临床症状改善优于对照组 (P <0 .0 1) ;血清肝纤维化指标HA、PCⅢ、CⅣ、LN等经 1个疗程治疗明显下降 (P <0 .0 1) ,与对照组相比 ,差异有显著性意义 (P <0 .0 1)。结论Objective: To observe the efficacy of Huaqian Decoction for the treatment of hepatic fibrosis, and develop the new drugs for counteracting hepatic fibrosis. Methods: 87 cases of chronic hepatopathy were treated with Huaqian Decoction in a half of year, and 87 cases were treated with colchicines as control. Results: The efficacy of treatment group was equivalent to control group ( P >0.05), whenas the clinical symptom was excelled than the control group. The serum parameter of hepatic fibrosis such as HA,PCⅢ,CⅣ and LN had declined markedly after a course ( P <0.01 ), with a significant difference contrasted with the control group. Conclusion: Huaqian Decoction has a remarkable curative effect on the hepatic fibrosis of chronic hepatopathy. \[

关 键 词：慢性肝病 肝纤维化 化纤方 临床研究 

分 类 号：R256.4[医药卫生—中医内科学]